Pedim 2014 Final Scientific Programme

1
PEDIM 2014
Welcome
to Prague!
Prague European Days
of Internal Medicine
18–20 September, 2014
Prague, Czech Republic
Final Programme

2 PEDIM 2014 Prague European Days of Internal Medicine Prague European Days of Internal Medicine
18–20 September, 2014 18–20 September, 2014
PEDIM 2014 3
CONTENTS
WELCOME LETTER 3
COMMITTEES 4
CONGRESS SECRETARIAT 4
CONGRESS VENUE 5
REGISTRATION 5
SOCIAL EVENT 6
INFORMATION FOR PARTICIPANTS 6
INFORMATION FOR SPEAKERS 7
ABSTRACTS 7
ON-SITE POSTER INSTRUCTIONS 8
CONGRESS VENUE MAP 9
PROGRAMME OVERVIEW 10
SCIENTIFIC PROGRAMME 12
– Thursday, September 18, 2014 12
– Friday, September 19, 2014 17
– Saturday, September 20, 2014 22
INDUSTRY SUPPORTED SYMPOSIUM 23
GENERAL INFORMATION 24
LIST OF POSTERS 25
PARTNERS 39
WELCOME LETTER
Dear Esteemed Colleagues and Friends,
Please allow me to cordially welcome you to Prague on behalf of the Organizing
Committee of the Prague European Days of Internal Medicine (PEDIM) Congress.
I assure you that we have done our utmost to ensure that your congress is both
enlightening and enjoyable. That having been said, it is veritably impossible to organize
such an event without encountering a few minor issues along the way. Should any arise,
I do hope you will fi nd it possible to overlook them in light of our beautiful “City of a
Hundred Spires.“ Prague has a very special atmosphere, which developed out of history,
tradition, art, architecture, culture and a sense for the fi ner things in life. I trust that you
will avail yourselves of this opportunity to experience the unique ambience of our city.
First and foremost, however, we have convened to deliberate matters pertaining to
internal medicine, the very cornerstone of complex, integrated medical care. The objective
of this congress is to improve the current state of health care in our countries. At present,
it is characterized by an ageing population; metabolic, cardiovascular and other non-infectious
disease epidemics; and is further compounded by diffi cult economic times.
Treatment for this polymorbid population is available through various specialists and
super-specialists whose integrated approach is supported by high-quality primary care
systems that embrace super-specialized, costly care in precisely-defi ned situations.
In addition, the tremendous scientifi c benefi ts of plenary lectures, case reports, posters
and other presentations will be invaluable.
I would also like to express my thanks and appreciation to the medical opinion leaders
who graciously accepted our invitation to join the international organizing committee
and advisory board.
A few years ago, some believed internal medicine to be a dying fi eld; one that had
already been superseded by other branches of medicine. This is no longer the case:
Internal medicine is not dying. Just as the mythical phoenix rose from its own ashes,
so too has internal medicine and I fi rmly believe that PEDIM will provide more than
suffi cient evidence to confi rm the continuing importance of our discipline.
I wish all of you a wonderful stay in Prague and I sincerely hope that PEDIM will prove
to be an interesting, productive and unforgettable event for all of us.
Prof. Richard Ceska, MD, PhD, FACP, FEFIM
President of the Czech Society of Internal Medicine
Congress President, PEDIM 2014

PEDIM 2014 5
COMMITTEES
Local Organising & Steering Committee
Richard Ceska, Czech Republic – Congress President PEDIM 2014
Jiri Widimsky jr., Czech Republic – Chair of Programme Committee
Michal Vrablik, Czech Republic – Member of Organizing Committee
Miroslav Soucek, Czech Republic – Member of Organizing Committee
Jindrich Spinar, Czech Republic – Member of Organizing Committee
International Organising & Steering Committee
Philip Barter, Australia – President IAS
Jean-Charles Fruchart, France – President R3i
Peter M Nilsson, Sweden
Ivica Lazurova, Slovakia
Dror Dicker, Israel
Klaus Parhofer, Germany
Antonio M. Gotto, USA
Henry N. Ginsberg, USA
Supporting Societies
CONGRESS SECRETARIAT
GUARANT International
Na Pankraci 17, 140 21 Prague 4
Czech Republic
Phone: +420 284 001 444
Fax: +420 284 001 448
E-mail: pedim@guarant.cz
CONGRESS VENUE
Diplomat Hotel Prague
Public transport: metro line A (green line), Dejvicka station
Address: Evropska 15, 160 41 Prague 6, Czech Republic, www.diplomathotel.cz
REGISTRATION
Registration Fees
On-site Fee (€)
Delegates 480 €
Young Internists (up to 35 years) 380 €
The registration fee includes:
• Attending all Congress Scientifi c Sessions
• Admission to the Exhibition Area and Poster Session
• Final Programme, Abstract Book on CD and other congress materials
• Coff ee breaks
Registration opening hours on-site
Wednesday, September 17 17:00–20:00
Thursday, September 18 07:30–17:00
Friday, September 19 08:30–17:00
Saturday, September 20 08:30–13:00

PEDIM 2014 7
INFORMATION FOR SPEAKERS
How to submit your presentation at the Congress
Please come to the Speakers´ Ready Room (Belvedere VI) at least 1 ½ hour before
the beginning of your session. In case your speech has been scheduled for morning
session please come to the Speakers´ Ready Room (Belvedere VI) one day before the
day of your presentation.
Speakers´ Ready Room (Belvedere VI) location is marked in the fi nal programme
brochure.
Opening hours of the Speakers Ready Room
Wednesday, September 17, 2014 18:00–20:00
Thursday, September 18, 2014 08:00–17:00
Friday, September 19, 2014 08:00–17:00
Saturday, September 20, 2014 08:30–12:00
• During your lecture you will be using Remote Control for controlling your
presentation
• Your own notebook is allowed to use for presentation only after discussion with
technician on-site
• All presentations will be deleted from all the PC used during the Congress
• Please be in your Session room at least 15 minutes prior to the start of the Session
• Make yourself known to the chairpersons and/or the room assistant (technician) in
your session room before the beginning of the session
• You are kindly asked to keep your presentation within the given time limits, which
also include discussion time. The chairpersons of your session will be strict in
allowing no more than the time allotted to your lecture: Remember to allow some
time for the changeover of speakers and chairperson‘s introduction, and for
questions and discussion
ABSTRACTS
The Prague European Days of Internal Medicine abstracts are available on CD as part
of the congress materials.
SOCIAL EVENT
Gala dinner
Date: Thursday, September 18, 2014
Time: 19:00
Place: CD Restaurant, Diplomat Hotel Prague
Price: 50 €
The Gala dinner will take place right at the congress venue. CD restaurant is situated on
the ground fl oor of the Hotel Diplomat and we have prepared 3 course menu.
INFORMATION FOR PARTICIPANTS
UEMS/EACCME Credits
We are happy to announce that the Prague European Days of Internal Medicine was
granted 14 European CME credits (ECMEC) by the European Accreditation Council for
Continuing Medical Education (EACCME).
Feedback Form
The rules of the EACCME state that participants are kindly asked to fi ll in the feedback
form included in the congress materials.
Badges
Only participants who are wearing their name badge will be admitted to the lecture
halls.

PEDIM 2014 9
ON-SITE POSTER INSTRUCTIONS CONGRESS VENUE MAP
Each poster will be displayed for 2 days, on Thursday, September 18 and on Friday,
September 19.
Posters can be displayed on their assigned board from 18:00 on Wednesday,
September 17. Posters must be removed on Friday, September 19 no later than 18:00.
Any posters remaining will be removed and destroyed and the congress will not keep
any posters for later collection.
Poster mounting times
Wednesday, September 17 18:00–20:00
Poster viewing
Poster removal times
Fixing material will be available at the Poster Area.

PEDIM 2014 11
PROGRAMME OVERVIEW
Thursday, September 18, 2014 Thursday, September 18, 2014
Meeting Hall Prague Meeting Hall Belvedere
08:30–09:00
Opening ceremony
Invasive cardiology [ ]
08:30–09:00
09:00–10:00
Free communication
Case reports – Rare diseases
09:00–10:00
10:00–11:00 Hypertension [ ] Free communication
Case reports – Infectious diseases / Rheumatology
10:00–11:00
11:00–11:30 Coff ee break Coff ee break 11:00–11:30
Industry Sponsored Symposium
11:30–12:30
Hypertension and Hyperuricemia
Free communication
Case reports – Gastroenterology / Endocrinology
11:30–12:30
12:30–14:00 Break for lunch Break for lunch 12:30–14:00
14:00–15:00 Preventive cardiology – lipids – R3i [ ] Free communication
Young internists
14:00–15:00
15:00–16:00
Continuous
Coff ee
break
Hot topics in internal medicine I
Free communication
Cardiology 1
Continuous
Coff ee
break
15:00–16:00
16:00–17:00 Diabetes and metabolic syndrome [ ] Free communication
Cardiology 2
16:00–17:00
Friday, September 19, 2014 Friday, September 19, 2014
Meeting Hall Prague Meeting Hall Prague A Meeting Hall Belvedere
09:00–10:00 Nephrology SreenProFH* 1 09:00–10:00
10:00–11:00 Rare diseases SreenProFH* 2 10:00–11:00
11:00–11:30 Coff ee break Coff ee break 11:00–11:30
11:30–12:30
Industry Sponsored Symposium
Dapaglifl ozin – beginning of a new era
in the management of type 2 diabetes?
SreenProFH* 3 11:30–12:30
12:30–14:00 Break for lunch Break for lunch 12:30–14:00
14:00–15:00 Atherosclerosis [ ] Free communication
Varia 1
14:00–15:00
15:00–16:00
Continuous
Coff ee
break
Endocrinology [ ] Free communication
Varia 2
Continuous
Coff ee
break
15:00–16:00
16:00–17:00 Gastroenterology
Free communication
Case reports – Varia
16:00–17:00
Saturday, September 20, 2014
MEETING Hall Belvedere
09:00–10:00 Rheumatology
10:00–11:00 Oncology
11:00–11:10 Coff ee break
11:10–12:10 Hot topics in internal medicine II
12:10–13:00 Closing ceremony
* ScreenPro is a screening project for Familial Hypercholesterolemia in Central,
Southern and Eastern Europe.
For Country representatives only.
[ ] This session is being simultaneously translated into Russian. Please pick up your
translation headphones at the registration desk.

PEDIM 2014 13
14:00–15:00 Preventive cardiology – lipids – R3i
Chair: J. Ch. Fruchart (France)
J. Ch. Fruchart (France):
Residual risk idea
H. Ginsberg (USA):
Statins, fi brates and diabetes mellitus
K. Parhofer (Germany):
Secondary hyperlipidaemias – focused on endocrine diseases
R. Ceska (Czech Republic):
Lomitapide in the treatment of LPL deffi ciency
15:00–16:00 Hot topics in internal medicine I
Chair: M. Markova (Czech Republic)
R. Ceska (Czech Republic):
New trends in treatment of dyslipidemias
M. Markova (Czech Republic):
Anemia
16:00–17:00 Diabetes and metabolic syndrome
Chair: M. Fried (Czech Republic)
D. Dicker (Israel):
Bariatric surgery for the diabetic patient – medical perspective
M. Fried (Czech Republic):
Bariatric surgery for the diabetic patient – surgeon perspective
SCIENTIFIC PROGRAMME
Thursday, September 18, 2014
Meeting Hall Prague
08:30–10:00 Opening Ceremony
Invasive cardiology
“Acute cardiology – Acute coronary syndromes”
Chair: R. Rokyta (Czech Republic)
P. Widimsky (Czech Republic):
Ongoing myocardial ischemia as criterion for early decision making
M. Studencan (Slovakia):
Slovak registry of ACS
R. Rokyta (Czech Republic):
Acute heart failure and cardiogenic shock
10:00–11:00 Hypertension
Chair: P. M. Nilsson (Sweden)
P. M. Nilsson (Sweden):
Hypertension and diabetes mellitus
J. Filipovsky (Czech Republic):
Pharmacological treatment of resistant hypertension
J. Widimsky jr (Czech Republic):
Nonpharmacological treatment of resistant hypertension
11:30–12:30 Industry Sponsored Symposium
J. Widimsky (Czech Republic):
Treatment of hypertension with comorbidities
J. Zavada (Czech Republic):
Gout and the kidney
12:30–14:00 Break for lunch
15:00–16:00
Continuous Coff ee break

PEDIM 2014 15
11:30–12:30 Free communication
Case reports – Gastroenterology / Endocrinology
Chair: G. Taskin (Turkey)
J. Farrukh (Great Britain):
Severe refractory coeliac disease with response only to parenteral
nutrition: a case report
K. Ozturk (Turkey):
A rare cause of ischemic colitis: colonoscopy
G. Taskin (Turkey):
A rare case; metronidazole-induced acute pancreatitis
A. I. Pelaez Ballesta (Spain):
Hypocalcemia and hypomagnesemia associated with proton pump
inhibitors
Young internists
Chair: A. Andrieieva (Ukraine)
A. Andrieieva (Ukraine):
Visfatin level in hypertensive patients with abdominal obesity against
the combination of antihypertensive therapy and atorvastatin
A. Babich (Russia):
Calcineurin inhibitors –induced arterial hypertension after liver
transplantation: single-center results.
D. Abdulganieva (Russia):
Evaluation of immune response to clostridium diffi cile in patients
with diff erent crohn‘s disease behavior
A. Kerimkulova (Kazakhstan):
The prevalence of selected cardiovascular disease in persons
exposed radiation due SNTS, Kazakhstan
Meeting Hall Belvedere
Case reports – Rare diseases
Chair: A.R. Barbosa (Portugal)
C. Cardoso (Portugal):
Spontaneous thoracic aortic rupture
L. Guedes (Portugal):
Hypokalaemia and metabolic alkalosis as presentation of ectopic
ACTH syndrome
P. M. Azevedo (Portugal)
Clinical challenges in the diff erential diagnosis of low back pain:
a case report
A. R. Barbosa (Portugal):
Coexistence of pernicious anemia and hashimoto‘s thyroiditis
in a 36 years old woman – a case report
R. Meireles (Portugal):
Sclerosing angiomatoid nodular transformation of the spleen –
a rare tumor
Case reports – Infectious diseases / Rheumatology
Chair: P.M. Moniz (Portugal)
Herpetic Encephalitis as secundary complication to
inmunosupression in patient with Multiple Myeloma
T. Bernardo (Angola):
Fever of unknown origin – massive infestation by ascaris
lumbricoides in pulmonary tuberculosis
J. Cunha (Portugal):
Multiple rare opportunistic diseases in an immunocompromised
patient with HIV: a case report
P. M. Moniz (Portugal):
Systemic sclerosis: obvious manifestations, late diagnosis

PEDIM 2014 17
Friday, September 19, 2014
Meeting Hall Prague
09:00–10:00 Nephrology
Chair: Z. Hruskova (Czech Republic)
M. Segelmark (Sweden):
Diagnostic and prognostic tools in glomerular disease
Z. Hruskova (Czech Republic):
New modes of treatment in glomerular disease
10:00–11:00 Rare diseases
Chair: V. Malinova (Czech Republic)
S. Moochhala (Great Britain):
Fabry disease: nephrologist´s view
L. Golan (Czech Republic):
Fabry disease: cardiologist´s view
V. Malinova (Czech Republic):
Lysosomal storage diseases and morbus Gaucher – situation
in the Czech Republic
11:30–12:30 Industry Sponsored Symposium
Dapaglifl ozin – beginning of a new era in the management
of type 2 diabetes?
M. Vrablik (Czech Republic):
Antidiabetic treatment and CVD risk reduction: wishful thinking
or reality?
D. Rahelic (Croatia):
Why should diabetologist be interested in dapaglifl ozin?
A. S. Lihn (Denmark):
Dapaglifl ozin – practical implications
Cardiology 1
Chair: H. Rosolova (Czech Republic)
15:00–16:00
A. Kilianova (Czech Republic):
Obstructive hyperthrophic cardiomyopathy and aortic valve disease
in elderly woman – a case for cathlab or surgery?
H. Rosolova (Czech Republic):
Residual cardiovascular risk in patients with stable coronary heart
disease over the last 16 years (Czech EUROASPIRE I-IV)
Infl uence of the 2011 Lorca earthquake on heart disease in the area
V. Gafarov (Russia):
Family stress in women and risk of myocardial infarction
and hypertension over 16 years in Russia: population-based
MONICA-psychosocial study
Cardiology 2
Chair: M. Vrablik (Czech Republic)
B. I. Lopez Benjume (Mexico):
Myocardial infarction risks factors in patients living in or outside
Mexico City
V. Gafarov (Russia):
Job stress eff ects on long-term risk of arterial hypertension and
myocardial infarction in female population aged 25-64 years
in Russia
D. Balaziova (Slovakia):
DNA diagnostics of familial hypercholesterolemia: Slovak experience
M. Vrablik (Czech Republic):
Atherosclerosis progression can be halted: an FH homozygote
without cardiovascular disease at the age of 40

PEDIM 2014 19
Meeting Hall Prague A
09:00–10:00 ScreenPro FH* 1
Underdiagnosed, undertreated risk factor of CVD
How to diagnose FH
How to fi nd FH
How to screen FH
Screening Programes
Why to build international network
Experience from MedPed
MedPed in the Czech Republic
ScreenPro FH
Introduction of the ScreenPro FH
What are our expectations
How to participate in ScreenPro FH
* ScreenPro is a screening project for Familial Hypercholesterolemia in Central,
Southern and Eastern Europe.
For Country representatives only.
14:00–15:00 Atherosclerosis
Chair: P. Barter (Australia)
P. Barter (Australia):
Introduction. IAS FH Initiative. Why, Who and Where?
K. Parhofer (Germany):
Familial Hypercholesterolaemia
A. M. Gotto jr (USA):
Recent and future therapy of FH – focused on PCSK9-i, mipomersen
and lomitapide
T. Freiberger (Czech Republic):
MedPed network – the Czech experience
15:00–16:00 Endocrinology
Chair: M. Krsek (Czech Republic)
15:00–16:00
W. M. Wiersinga (The Netherlands):
Thyroid investigations in populations at risk to develop autoimmune
thyroid disease
I. Lazurova (Slovakia):
Adrenal incidentalomas
P. F. Plouin (France):
Primary aldosteronism – update
16:00–17:00 Gastroenterology
“Current advances in clinical gastroenterology”
Chair: M. Lukas (Czech Republic)
B. Pekarek (Slovakia):
Progress in GI therapeutic endoscopy
P. L. Lakatos (Hungary):
New therapeutic modalities in IBD patients
J. Martinek (Czech Republic):
Role of PPIs in clinical practice in 2014 and beyond
P. Papay (Austria):
Evolving concept in colorectal cancer screening

PEDIM 2014 21
Case reports – Varia
Chair: A. A. Stan (Romania)
L. Costa (Portugal):
A reversible cause of heart failure. Call for withdrawal
A. A. Stan (Romania):
Deep left internal jugular and subclavian vein thrombosis-rare cause
manifestation
M. Nardi (Italy):
Pioglitazone-induced lung damage
I. Costa (Portugal):
Spinal cord compression by vertebral metastases as the presenting
form of hepatocellular carcinoma
Varia 1
Chair: C. Cardoso (Portugal)
C. Cardoso (Portugal):
Trends in the use of non-invasive ventilation in a internal medicine
ward
C. Mozzini (Italy):
Endoplasmic reticulum stress and Nrf2 repression in circulating cells
of type 2 diabetic patients without the recommended glycaemic
goals
E. V. Korneeva (Russia):
Gender diff erences of metabolic syndrome among young people
H. S. Gouveia (Portugal):
Mid-upper arm circumference: an important weapon for nutritional
screening in hospitalized medical patients
Varia 2
Chair: Z. Chmelik (Czech Republic)
15:00–16:00
M. Petrova (Russia):
Prevention of osteoporosis at North youth
R. Serras Jorge (Portugal):
Pneumocystis jirovecii pneumonia – 14 years of experience
in an intensive care unit
H. S. Gouveia (Portugal):
Diff erences in mortality of hospitalized patients under the age
of 65 – a two-year mortality assessment
Z. Chmelik (Czech Republic):
The eff ect of amaranth fl our on plasma cholesterol levels: another
option for cardiovascular risk lowering?

22 PEDIM 2014 18–20 September, 2014 Prague European Days of Internal Medicine
Prague European Days of Internal Medicine PEDIM 2014 23
18–20 September, 2014
Saturday, September 20, 2014
09:00–10:00 Rheumatology
Chair: J. Lukac (Slovakia)
J. Vencovsky (Czech Republic):
Immune mediated necrotising myopathy
New recommendations for diagnosis and treatment of gout
K. Pavelka (Czech Republic):
Therapeutic strategies in therapy of diff erent forms
of spondyloarthritides
J. Lukac (Slovakia):
Modern diagnostic and therapeutic approaches in scleroderma
10:00–11:00 Oncology
Chair: R. Gurlich (Czech Republic)
F. Lordick (Germany):
New targeted drug prolongs survival in advanced stomach cancer
R. Gurlich (Czech Republic):
Surgical management of gastric cancer
11:10–12:10 Hot topics in internal medicine II
Chair: M. Krsek (Czech Republic)
M. N. Mamedov (Russia):
Men health’s problems in cardiology
M. Krsek (Czech Republic):
When and how to screen patients for Cushing´s syndrome
V. Hainer (Czech Republic):
New antiobesity drugs
12:10–13:00 Closing Ceremony
INDUSTRY SUPPORTED SYMPOSIUM
Thursday September 18, 11:30–12:30, Meeting room Prague
Satellite Symposium supported by Berlin-Chemie
J. Widimsky (Czech Republic):
Treatment of hypertension with comorbities
Gout and the kidney
Friday, September 19, 11:30–12:30, Meeting room Prague
Satellite Symposium supported by Astra Zeneca
Dapaglifl ozin (Forxiga) – beginning of a new era in the management of type 2
diabetes?
Michal Vrablik (Czech Republic):
Antidiabetic treatment and CVD risk reduction: wishful thinking or reality?
Dario Rahelic (Croatia):
Why should diabetologist be interested in dapaglifl ozin?
Aina S. Lihn (Denmark):
Dapaglifl ozin – practical implications

PEDIM 2014 25
GENERAL INFORMATION
Public Transport
Please note – All registered participants will receive Free PUBLIC TRANSPORT TICKET
(received on-site at the registration desk and will be valid within the dates of the congress).
Prague has a very sophisticated subway, tram and bus transport system. The Prague
Underground is quite new and effi cient. At peak times, trains run every 2 or 3 minutes,
and during off -peak hours at least every 8–10 minutes.
Taxi Service
In the city centre, taxis are easy to hire from the street but we strongly recommend you
to use hotel taxis or to call a taxi by phone through the radio taxi service.
We recommend you to use following taxi companies:
Profi Taxi +420 261 314 151 or +420 14 0 15
AAA Taxi +420 222 333 222 or +420 14 0 14
Insurance
The organizers do not accept responsibility for individual medical, travel or personal
insurance. All participants are strongly advised to take out their own personal insurance
before travelling to the Convention.
Currency & Banking
Czech crown (CZK) is the offi cial currency of the Czech Republic. Exchange of foreign
currency is available at Prague international Airport and at most hotels, banks and
exchange offi ces throughout the city. International credit cards are accepted for
payments in hotels, restaurants and shops. Payment in cash in EUR is also available
in some restaurants and shops, please ask for details on-site. You can fi nd the offi cial
exchange rates on the website of the Czech National Bank at www.cnb.cz.
Shopping
Most shops in Prague are open from 9:00 to 18:00, Monday to Saturday. Shops in the city
centre are usually open from 9:00 to 20:00, Monday to Sunday.
Useful telephone numbers
112 – General Emergency for Europe
150 – Fire alarm
155 – Ambulance
156 – Prague Police
158 – State Police
LIST OF POSTERS
Legend
ID Title of the poster
Name of the author / authors
POSTERS
Noninvasive cardiology
13 Diagnostic value of galectin-3 in patients with Heart Failure
K. Gyamdjyan, M. Maximov
15 Certain determinants of quality of life in patients with chronic heart
failure of ischemic origin
M. Vatutin, M. Khrystychenko, O. Kieting, A. Zagoruiko
25 R wave amplitude of aVL derivation seems to be important in predicting
arterial stiff ness parameters
H. Sarlak, F. Bulucu, E. Arslan, S. Demirbas, M. Akhan, S. Demirkol
44 Short training in focused cardiac ultrasound in an Internal Medicine
department: what realistic skill targets could be achieved?
C. Mozzini, L. Cominacini, A. Fratta Pasini
66 Early and long-term cardiovascular complications after orthotopic liver
transplantation.
A. Babich, E. Kosmacheva
111 Impact of Framingham Risk Score, Flow-Mediated Dilation, Pulse Wave
Velocity, and Biomarkers for Cardiovascular Events in Stable Angina
K. H. Park, W. J. Park, S. J. Han, H. S. Kim, S. H. Jo, S. A. Kim
112 Osteoprotegerin Gene Polymorphism Is Not Associated With
Angiographic Coronary Artery Stenosis and Calcifi cation in Korean
W. J. Park, K. H. Park, H. S. Kim, S. H. Jo, S. A. Kim
113 Urinary NGAL levels in patients with acute and chronic heart failure
M. Dankova, T. Pazmanova, J. Gergel, I. Gaborikova, P. Pontuch
128 Outcomes of lesions with positive remodeling using coronary
multi-detector row computed tomography (MDCT) data analysis
S. U. Kwon
131 Levosimendan use in the intensive care patient and its impact on renal
and hepatic function
J. R. Pereira

PEDIM 2014 27
135 Outcome after treatment with Levosimendan according to the etiology
of heart failure - the perspective of an Intensive Care Unit
J. R. Pereira
Hypertension
23 Dipping Status in Individuals Monitored by Ambulatory Blood Pressure
Measurements
H. Sarlak, F. Bulucu, E. Arslan, S. Demirbas, K. Saglam
68 Does it only reduction of arterial pressure determines the eff ectiveness
of antihypertensive pharmacotherapy?
O. Kompaniets, A. Ponomareva, V. Pokrovskii
81 Diastolic function of the left and right ventricles in hypertensive patients
A. Kerimkulova, A. Markabayeva, T. Rakhypbekov, L. Pivina
129 Current status of hypertension in Korean people: data from a heart day
campaign
S. U. Kwon
Gastroenterology
16 Detection of Colorectal Neoplasm using promoter methylation of stool
DNA in Korean patients
J. H. Yoo, D. I. Park
30 The relationship of metabolic disorders and severity of liver disease with
gene polymorphism ?2- adrenergic receptor in chronic hepatitis C
I. A. Bulatova, A. P. Schekotova, N. I. Nasibullina, V. V. Shchekotov
42 Polymorphism eNOS3 (rs1799983) gene and its relationship with
the severity of infl ammation in chronic hepatitis C and ulcerative colitis
I. A. Bulatova, Y. I. Tretyakova, V. V. Shchekotov, A. P. Schekotova
51 Effi ciency of Rifampicin in Emergency Treatment of Severe Intrahepatic
Cholestasis
K. Ozturk, H. Demirci, Y.S. Sakin, A. Uygun, S. Bagci
67 Pulse Wave Velocity in Patients with Normotensive and Normoglysemic
Ulcerative Colitis
K. Ozturk, M. Gulsen, A.K. Guler, M. Cakir, S. Demirbas, M. Gezer, H. Demirci,
Y. S. Sakin, A. Uygun, S. Bagci
70 MEFV gene mutation frequency in patients with acute pancreatitis and its
clinical importance
G. Taskin, S. Sayin, B. Koc, D. Torun, G. Buyukturan, E. Arslan, Y. Tunca, K. Saglam
Haematology
32 Changes in platelet count in an internal medicine ward
D. Barchel, I. Tzur, M. Shteinshnaider, D. Almoznino-Sarafi an, N. Tsatsanashvili,
M. Swarka, N. Cohen, O. Gorelik
76 Non-Hodgkin’s lymphoma diff use large B cell patients in more than
80 years old
K. Natori, D. Nagase, S. Ishihara, A. Sakai, M. Kato, Y. Kuraishi, H. Izumi
77 Multiple neoplasms consist of esophangeal cancer and hematological
malignancy
K. Natori, S. Ishihara, D. Nagase, A. Sakai, M. Kato, Y. Kuraishi, H. Izumi
96 Venous thromboembolic prophylaxis; is decision making consistent
A. Salam, M. Haji-Coll, C. Lisk
Infectious diseases
33 Rare case of constrictive pericarditis due to combined Actinomyces-
Fusobacterium infection
I. Tzur, I. Reznick, D. Almoznino-Sarafi an, M. Shteinshnaider, N. Cohen, O. Gorelik
53 Levofl oxacin induced proximal miopathy
L. Tiosano, J. Bathish, G. Buzarov, A. Zeidman
56 Diagnosis and treatment of Chlamýdia trachomatis infection- case report
E. Janekova, P. Ziak
57 Acute Q fever: Description of two cases with atypical presentation
E. Papadimitriou, A. Masgala, E. Karabousli, M. Kalyvas, L. Lanaras
58 Pneumococcal Septic polyarthritis revealing smoldering myeloma
A. Silawy, G. Lavie, S. Perek, D. Zisman, G. Weber, S. Cohen
59 Endogenous endophthalmitis as the presenting symptom of klebsiella
pneumonia bacteremia of urinary origin – rare complication of common
disease
G. Lavie, A. Zoabi, G. Weber, S. Cohen
62 An unusual case of afebrile endocarditis presenting as purpura and acute
renal failure
G. Lavie, A. Silawy, G. Weber, S. Cohen
100 Pandemic h1n1 infl uenza vs seasonal infl uenza – a dangerous virus
today?
M. J. Anaya, P. Azevedo, J. Patrocinio, E. Leite, F. Aldomiro

PEDIM 2014 29
101 Kidney and vertebral tuberculosis
C. Madaleno, N. Jacinto, G. Vieira, P. Rocha, J. Meneses Santos
110 Enteric Parasites in Children from São Tomé and Príncipe: a Window
for Prevention
J.B. Augusto, M.L. Lobo, J. Ceita, O. Matos
121 Active tuberculosis in patients over 65
J. Nieto-LopezGuerrero, J. F. Pascual-Pareja, M. Martinez-Prieto,
R. Carrillo-Gomez, C. Garcia-Cerrada, A. Noguerado-Asensio
136 Are we using sharps bins appropriately?
M. Haji-Coll, J. Olatujoye, C. Huang, C. Lisk
Various
40 Malignant fi brous histiocytoma in the heart; autopsy case
S. Furukawa, S. Morita, K. Nishi, M. Hitosgugi
48 The Associated Between Pulse Wave Velocity and Mean Platelet Volume
in Patients with Infl ammatory Bowel Disease
M. Gezer, M. Cakir, A.K. Guler, T. Dogan, K. Ozturk
126 Antithrombotic therapy prescription for the prevention of stroke:
patterns of underuse in Krasnodar patients with atrial fi brillation
A. Ponomareva, O. Kompaniets, R. Linchak, L. Prutskaya, Y. Saibel
29 Diabetes care in hemodialysis patients; what can we improve
Z. Dimitrijevic, K. Paunovic, M. Stojanovic, J. Kostic, S. Ljubenovic
114 A New Opinion on the Etiopathogenesis of RLS and Sleep Disorders
in Patients Undergoing Chronic Dialysis: Infl ammation
A. Acay, A. Ahsen, M. S. Ulu, S. Oruc, M. Sariaydin, S. Yuksel, G. Acarturk
61 Measurement of random capillary blood glucose at admission
J. Green, H. Dadds, M. Hajj-coll, R. Garg, P. Jacobs
11 Prerequisites for the comprehensive evaluation of patients with gout
in Yakutia
M. Petrova
18 Chalanges in treating a patient with psoriathic arthropaty and hepatic
involvement
M. P. Duna, V. C. Bojinca, R. Ionescu
36 Service improvement project investigating neutropenic sepsis
admissions at barnet general hospital
C. Tang, M. Haji-Coll, P. Jacobs
93 Multiple myeloma - series of diff erent clinical presentations
V. Carapichoso, T. Monteiro, A. Abreu, N. Andrade, A. Obregon, M. Neto
102 Mucoepidermoid carcinoma of the salivary gland - a clinical challenge
M. J. Anaya, P. Azevedo, J. Patrocinio, E. Leite, F. Aldomiro
38 Pseudopheocromocytoma a rare case of refractory hypertension
L. Frade, A. Ribeiro Cunha, L. Costa, M. Miguens, L. Campos
10 Results of a multi-centre audit to improve doctors‘ awareness of DVLA
guidelines
M. Maruthappu, J. Farrukh, B. Green, T. Soomro, N. D. Gollop, R. A. Watson,
J. C. R. Wormald, M. Park, J. Shalhoub, K. Y. B. Ng
45 Alcohol use and drinking motives among Korean medical students
S. Y. Lee
46 Dignity of death and quality of end-life process
G. Lara Martinez, A. I. Pelaez Ballesta, M. M. Molina Morales, V . Martínez Pagán,
M. Miluy Guerrero, F. Escobar Gomez-Villalba, E. Mene Fenor
72 Hyponatremia in critically ill patients
L. Yamanel, G. Taskin, M. Eser, A. Kilinc, K. Kara, E. Tekgoz, N. G. Somak
86 Frailty syndrome and hopitalization time in an internal medicine
department - a prospective observational study
A. R. Barbosa, A. R. Ramos, O. Gonçalves, V. Paixão
98 Venous thromboembolism prophylaxis in an Internal Medicine Ward
R. Meireles, I. Costa, D. Ferreira, V. Iglesias, P. Baptista
120 A less common iatrogenic complication of unpredictable end
L. Costa, F. Marques, A. Botella, D. Romeira, P. Moniz, A. Leitão, C. Fonseca,
F. Ceia
124 Screening examination of the Kazakhstan population exposed to
radiation
A. S. Kerimkulova, L. M. Pivina, T. I. Belikhina, A. M. Markabaeva,
T. K. Rakhypbekov, K. N. Apsalikov, A. K. Akhmetova, Z. Yensegenova

PEDIM 2014 31
130 The anti-infl ammatory eff ect of pulmonary renin angiotensin system
blockade by intratracheally administered losartan
I. L. Gurzu, L. G. Vata, E. Cojocaru, D. Ungureanu, F. Mitu, B. Gurzu
134 Computerized tomography before lumber puncture for suspected CNS
infection – not always necessary and causing delays?
H. Ahmed, P. Glynne, A. Morin
139 The junior vision about safety culture
I. B. Mesquita, J. A. Monteiro, M. Pires, L. Carvalho, A. Pereira
Case Reports
105 Resistant hypertension and RSD: is it possible to foresee
a non-responder patient?
F. Cagnoni, G. P. Dognini, S. Panza, E. Gorla, A. Besozzi, A. Belotti Masserini,
P. Colombelli, V. Galimberti, C. Cavalleri, M. Destro
90 Extraganglionar lymphoma - a clinical case
T. Bernardo, E. Freitas, V. Carapichoso, A. Abreu, N. Andrade, M. Neto
127 Kearns-Sayre Syndrome: The integrative role of internal medicine
specialists
E. Cagiltay, F. Akay, S. Toyran, M. Atalay, A. Bakir
95 Peritoneal tuberculosis - from diagnosis to treatment
V. Carapichoso, J. Chivia, E. Freitas, T. Bernardo, A. Abreu, N. Andrade, M. Neto
99 Retroperitoneal hematoma: a diff erential diagnosis to keep in mind
C. Madaleno, N. Jacinto, F. Trigueiros, A. J. Pedro, J. Meneses Santos
138 Orbital infl ammatory pseudotumor as fi rst manifestation of a breast
lobular carcinoma
V. Martinez Pagan, A. Pelaez Ballesta
LAST MINUTE POSTERS
Hypertension
145 Comparison the incidence of top ten types of cancers among Iraqi
population before and after the 3rd Gulf war 2003
S. Ali - Sadiam H. + Ali
Noninvasive cardiology
146 Blood pressure and blood pressure variability: implications, challenges,
and perspectives
E. V. Pello, S. K. Malyutina, E. G. Verevkin, G. I. Simonova, Y. P. Nikitin
Various
147 Discharge summaries audit: Is secondary care communicating safely
and accurately back to primary care?
H. Ahmed, S. Savla, M. Hogan, A. Radia, S. Mitchell
Clinical Biochemistry
148 Correlation between hypernatremia severity and patients ages on icu
admission
G. Taskin, M. Eser, K. Kara, N. G. Somak, A. Kilinc, L. Yamanel
Infectious diseases
149 A rare case of secondary vasculitis
M. J. Anaya, P. M. Azevedo, J. Patrocínio, E. Leite, F. J. Aldomiro
Rheumatology
150 How to improve early diagnosis of axial spondyloarthritis (according
to Rheumatologic city Center, Kazan, Russia)
S. A. Lapshina, L. I. Myasoutova, Sh. F. Erdes
151 10-year probability of osteoporotic fracture using FRAX program
A. G. Vasilyev, D. I. Abdulganieva, L. I. Myasoutova
152 Eff ectiveness of educational activities for patients with osteoporosis
L. I. Myasoutova, S. A. Lapshina

PEDIM 2014 33
NOTES

PEDIM 2014 35

Prague European Days of Internal Medicine 18–20 September, 2014
PEDIM 2014 39
PARTNERS
The organizing committee would like to thank to all partners
for their strong support!
Silver Partner
Bronze Partners
Partners
Media Partners
Poorly controlled LDL-C continues
to loom over millions of lives1
Despite treatment with statins, millions of high-risk patients with hypercholesterolemia
in the US continue to have poorly controlled LDL-C and are at persistent cardiovascular
risk.2
Sanofi and Regeneron are committed to providing resources to better understand
cholesterol management and to research the unmet needs of patients with poorly
controlled LDL-C.
LDL-C = low-density lipoprotein cholesterol.
References: 1. Pöss J, Custodis F, Werner C, Weingärtner O, Böhm M, Laufs U. Cardiovascular disease and dyslipidemia: beyond LDL.
Curr Pharm Des. 2011;17:861-870. 2. Jones PH, Nair R, akker KM. Prevalence of dyslipidemia and lipid goal attainment in statin-treated
subjects from 3 data sources: a retrospective analysis. JAHA. 2012;1:1-10. doi:10.1161/JAHA.112.001800.
©2014, Sanofi and Regeneron Pharmaceuticals, Inc. | CZ.MTB.14.08.05
sanofi –aventis, s.r.o., Evropská 846/176a, 160 00 Praha 6, tel.: 233 086 111, fax: 233 086 222, www.sanofi .cz
REGENERON
Going beyond today

PEDIM 2014
CONGRESS SECRETARIAT
GUARANT International spol. s r. o.
Na Pankraci 17, 140 21 Prague 4
Czech Republic
Tel: +420 284 001 444
E-mail: pedim@guarant.cz
WWW.PEDIM2014.ORG

Pedim 2014 Final Scientific Programme

Recommandé

Recommandé

Contenu connexe

En vedette

En vedette (18)

Similaire à Pedim 2014 Final Scientific Programme

Similaire à Pedim 2014 Final Scientific Programme (20)

Dernier

Dernier (20)

Pedim 2014 Final Scientific Programme